- Home
- FLNA vs MNY Comparison
FLNA vs MNY Comparison
Compare FLNA & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLNA | MNY |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | Singapore |
| Employees | 20 | 240 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 58.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FLNA | MNY |
|---|---|---|
| Price | $1.22 | $0.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 320.5K | 68.7K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $0.78 |
| 52 Week High | $2.03 | $2.40 |
Technical Indicators
Market Signals| Indicator | FLNA | MNY |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 30.82 |
| Support Level | $1.16 | N/A |
| Resistance Level | $1.80 | $1.46 |
| Average True Range (ATR) | 0.07 | 0.13 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 44.44 | 26.90 |
Price Performance
Historical ComparisonAbout FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
About MNY MoneyHero Limited
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.